Top 20 of Glaucoma

Article title # Publications/# Citations

The number of people with glaucoma worldwide in 2010 and 2020.

2006: ATBroman; HAQuigley;

528

Causes and prevalence of visual impairment among adults in the United States.

2004: Eye Diseases Prevalence Research Group; NCongdon; DSFriedman; JKempen; CCKlaver; RKlein; PMitchell; BMunoz; BO'Colmain; HRTaylor;

321

Number of people with glaucoma worldwide.

1996: HAQuigley;

316

The classical complement cascade mediates CNS synapse elimination.

2007: NJAllen; BABarres; KSChristopherson; GRHowell; ADHuberman; SWJohn; JDLambris; AMLitke; ... AKMehalow; KDMicheva; NNouri; ASher; SJSmith; BStafford; BStevens; LEVazquez;

271

Global data on blindness.

1995: KYDadzie; ADNégrel; RPararajasegaram; BThylefors;

168

Common sequence variants in the LOXL1 gene confer susceptibility to exfoliation glaucoma.

2007: AArnarsson; DFGudbjartsson; JRGulcher; GAHardarson; AJonasdottir; AJonasdottir; FJonasson; TJonsson; ... AKong; KPMagnusson; GMasson; MMotallebipour; HPétursson; GStefansdottir; HStefansson; KStefansson; PSulem; GThorleifsson; UThorsteinsdottir; CWadelius; OWallerman; GBWalters;

155

The definition and classification of glaucoma in prevalence surveys.

2002: RBuhrmann; PJFoster; GJJohnson; HAQuigley;

134

The Framingham Eye Study monograph: An ophthalmological and epidemiological study of cataract, glaucoma, diabetic retinopathy, macular degeneration, and visual acuity in a general population of 2631 adults, 1973-1975.

1980 May-Jun: TLColton; TRDawber; JPGanley; HAKahn; MMKini; DEKrueger; HMLeibowitz; JILoewenstein; ... LRMaunder; RCMilton; RJNickerson; JPool;

129

Comparison of glaucomatous progression between untreated patients with normal-tension glaucoma and patients with therapeutically reduced intraocular pressures. Collaborative Normal-Tension Glaucoma Study Group.

1998:

127

Optic nerve damage in human glaucoma. III. Quantitative correlation of nerve fiber loss and visual field defect in glaucoma, ischemic neuropathy, papilledema, and toxic neuropathy.

1982: EMAddicks; WRGreen; HAQuigley;

127

Mechanisms involved in the side effects of glucocorticoids.

2002: KAsadullah; WDDöcke; HSchäcke;

124

Optic nerve damage in human glaucoma. II. The site of injury and susceptibility to damage.

1981: EMAddicks; WRGreen; AEMaumenee; HAQuigley;

123

Retinal ganglion cell death in experimental glaucoma and after axotomy occurs by apoptosis.

1995: LAKerrigan; RWNickells; MEPease; HAQuigley; DJThibault; DJZack;

121

Clinically detectable nerve fiber atrophy precedes the onset of glaucomatous field loss.

1991: JKatz; NRMiller; HAQuigley; RCRichter; ALRobin; ASommer; KAWitt;

120

The impact of ocular blood flow in glaucoma.

2002: VPCosta; JFlammer; GKKrieglstein; SOrgül; NOrzalesi; JPRenard; LMSerra; EStefánsson;

119

Axons of retinal ganglion cells are insulted in the optic nerve early in DBA/2J glaucoma.

2007: JMBarbay; JWBarter; GRHowell; TCJakobs; SWJohn; RTLibby; NMahesh; JKMarchant; ... RHMasland; FCPhalan; VPorciatti; RSSmith; AVWhitmore;

117

Quantification of nerve fiber layer thickness in normal and glaucomatous eyes using optical coherence tomography.

1995: JGFujimoto; MRHee; EHertzmark; JAIzatt; CPLin; TPedut-Kloizman; CAPuliafito; JSSchuman; EASwanson; CWong;

113

11beta-hydroxysteroid dehydrogenase type 1: a tissue-specific regulator of glucocorticoid response.

2004: IJBujalska; MSCooper; NDraper; MHewison; GGLavery; PMStewart; JWTomlinson; EAWalker;

112

Analysis of myocilin mutations in 1703 glaucoma patients from five different populations.

1999: WLAlward; YMBuys; JECraig; JDickinson; JHFingert; EHéon; RRHockey; STHoh; ... KKawase; YKitazawa; JMLiebmann; DAMackey; JRait; RRitch; VCSheffield; EMStone; GTrope; DWilliams-Lyn; TYamamoto;

111

Neuronal death in glaucoma.

1999: HAQuigley;

110